Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federico Perez

Showing results (1-10 of 160) with videos related to

Pageof 16
Sort By:
Mbio|May 13, 2022
The Impact of Natural Transformation on the Acquisition of Antibiotic Resistance DeterminantsFederico Perez, Usha Stiefel
Antimicrobial Agents and Chemotherapy|November 20, 2019
Precision Medicine and Mysteries in Clinical Microbiology: Rationalizing Epidemiology, Genotype, and Phenotype To Guide TherapeuticsFederico Perez, Robert A Bonomo
The Lancet. Infectious Diseases|February 20, 2018
Evidence to improve the treatment of infections caused by carbapenem-resistant Gram-negative bacteriaFederico Perez, Robert A Bonomo
The Lancet. Infectious Diseases|May 4, 2019
Carbapenem-resistant Enterobacteriaceae: global action requiredFederico Perez, Robert A Bonomo
The New England Journal of Medicine|May 16, 2019
Cardiac Devices Enveloped with an Ounce of PreventionFederico Perez, Robert A Bonomo
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 8, 2011
Can we really use ß-lactam/ß-lactam inhibitor combinations for the treatment of infections caused by extended-spectrum ß-lactamase-producing bacteria?Federico Perez, Robert A Bonomo
The Lancet. Infectious Diseases|June 8, 2020
Colistin resistance in China: from outer membrane to One HealthFederico Perez, Robert A Bonomo
The Lancet. Microbe|May 11, 2022
Genomic epidemiology of colistin-resistant Escherichia coli in ChinaFederico Perez, Robert A Bonomo
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 15, 2015
Editorial commentary: Bloodstream infection caused by extended-spectrum β-lactamase-producing Gram-negative bacteria: how to define the best treatment regimen?Federico Perez, Robert A Bonomo
Cleveland Clinic Journal of Medicine|April 3, 2013
Carbapenem-resistant Enterobacteriaceae: a menace to our most vulnerable patientsFederico Perez, David Van Duin
Pageof 16

Showing results (1-10 of 160) with videos related to

Sort By:
Pageof 16
Mbio|May 13, 2022
The Impact of Natural Transformation on the Acquisition of Antibiotic Resistance DeterminantsFederico Perez, Usha Stiefel
Antimicrobial Agents and Chemotherapy|November 20, 2019
Precision Medicine and Mysteries in Clinical Microbiology: Rationalizing Epidemiology, Genotype, and Phenotype To Guide TherapeuticsFederico Perez, Robert A Bonomo
The Lancet. Infectious Diseases|February 20, 2018
Evidence to improve the treatment of infections caused by carbapenem-resistant Gram-negative bacteriaFederico Perez, Robert A Bonomo
The Lancet. Infectious Diseases|May 4, 2019
Carbapenem-resistant Enterobacteriaceae: global action requiredFederico Perez, Robert A Bonomo
The New England Journal of Medicine|May 16, 2019
Cardiac Devices Enveloped with an Ounce of PreventionFederico Perez, Robert A Bonomo
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 8, 2011
Can we really use ß-lactam/ß-lactam inhibitor combinations for the treatment of infections caused by extended-spectrum ß-lactamase-producing bacteria?Federico Perez, Robert A Bonomo
The Lancet. Infectious Diseases|June 8, 2020
Colistin resistance in China: from outer membrane to One HealthFederico Perez, Robert A Bonomo
The Lancet. Microbe|May 11, 2022
Genomic epidemiology of colistin-resistant Escherichia coli in ChinaFederico Perez, Robert A Bonomo
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 15, 2015
Editorial commentary: Bloodstream infection caused by extended-spectrum β-lactamase-producing Gram-negative bacteria: how to define the best treatment regimen?Federico Perez, Robert A Bonomo
Cleveland Clinic Journal of Medicine|April 3, 2013
Carbapenem-resistant Enterobacteriaceae: a menace to our most vulnerable patientsFederico Perez, David Van Duin
Pageof 16